SI1590144T1 - Postopek za pripravo biološko aktivnih formulacij - Google Patents

Postopek za pripravo biološko aktivnih formulacij

Info

Publication number
SI1590144T1
SI1590144T1 SI200332446T SI200332446T SI1590144T1 SI 1590144 T1 SI1590144 T1 SI 1590144T1 SI 200332446 T SI200332446 T SI 200332446T SI 200332446 T SI200332446 T SI 200332446T SI 1590144 T1 SI1590144 T1 SI 1590144T1
Authority
SI
Slovenia
Prior art keywords
biologically active
active formulations
preparing biologically
preparing
formulations
Prior art date
Application number
SI200332446T
Other languages
English (en)
Inventor
Orapin P. Rubino
David M. Jones
Frank Bretschneider
Peter Fankhauser
Armin Prasch
Original Assignee
Nortec Development Associates, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nortec Development Associates, Inc. filed Critical Nortec Development Associates, Inc.
Publication of SI1590144T1 publication Critical patent/SI1590144T1/sl

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2/00—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic
    • B01J2/14—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic in rotating dishes or pans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2/00—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic
    • B01J2/003—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic followed by coating of the granules

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
SI200332446T 2002-12-10 2003-12-04 Postopek za pripravo biološko aktivnih formulacij SI1590144T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US43235102P 2002-12-10 2002-12-10
PCT/US2003/038720 WO2004052607A1 (en) 2002-12-10 2003-12-04 Method of preparing biologically active formulations
EP03796707.2A EP1590144B1 (en) 2002-12-10 2003-12-04 Method of preparing biologically active formulations

Publications (1)

Publication Number Publication Date
SI1590144T1 true SI1590144T1 (sl) 2015-11-30

Family

ID=32507909

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200332446T SI1590144T1 (sl) 2002-12-10 2003-12-04 Postopek za pripravo biološko aktivnih formulacij

Country Status (9)

Country Link
EP (1) EP1590144B1 (sl)
JP (3) JP2006509803A (sl)
CN (2) CN1747822A (sl)
AU (1) AU2003298945A1 (sl)
CA (1) CA2509043C (sl)
DK (1) DK1590144T3 (sl)
ES (1) ES2545454T3 (sl)
SI (1) SI1590144T1 (sl)
WO (1) WO2004052607A1 (sl)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL1753398T3 (pl) * 2004-06-10 2019-04-30 Glatt Air Techniques Inc Macierz o kontrolowanym uwalnianiu farmaceutycznej formulacji dawkowania
CA2569961A1 (en) * 2004-06-10 2005-12-29 Glatt Air Techniques, Inc Controlled release pharmaceutical formulation
WO2006090845A1 (ja) 2005-02-25 2006-08-31 Takeda Pharmaceutical Company Limited 顆粒の製造方法
EP1896002A4 (en) 2005-06-27 2009-11-25 Biovail Lab Int Srl BUPROPIONAL SALT FORMULATIONS WITH MODIFIED RELEASE
KR20080047571A (ko) * 2005-08-26 2008-05-29 비피에스아이 홀딩스, 엘엘씨. 방출 조절 하이프로멜로스 매트릭스를 포함하는 약학조성물
US9555387B2 (en) 2008-02-14 2017-01-31 Element Six Limited Method for manufacturing encapsulated superhard material
CN101910354B (zh) * 2008-02-14 2013-10-16 六号元素有限公司 制造包封的超硬材料的方法
DE102008048729A1 (de) 2008-09-24 2010-03-25 Add Technologies Ltd Advanced Drug Delivery Multipartikuläre Tabletten und Verfahren zur deren Herstellung
WO2011155451A1 (ja) 2010-06-08 2011-12-15 学校法人神戸学院 コーティング粒子及びコーティング粒子の製造方法
US20170042806A1 (en) 2015-04-29 2017-02-16 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
CN108836948B (zh) * 2018-06-11 2024-04-12 宁波西敦医药包衣科技有限公司 一种利用包衣技术实现营养素可控制释放的产品
BR112021001323A2 (pt) 2018-07-18 2021-04-20 Glatt Gmbh formulações de liberação prolongada de canabinoides
EP3917500A2 (en) * 2019-01-31 2021-12-08 Elektrofi, Inc. Particle formation and morphology
AU2020316989B2 (en) * 2019-07-19 2024-02-15 The Global Alliance For Tb Drug Development, Inc. Pretomanid compositions
CN114028577B (zh) * 2021-10-20 2024-07-02 珠海市东辰制药有限公司 一种二氧化硅丸芯及其制备方法
US11896719B2 (en) 2022-01-24 2024-02-13 Calliditas Therapeutics Ab Pharmaceutical compositions

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1233163B (it) * 1989-03-01 1992-03-14 Zanchetta Aldo Procedimento di sferonizzazione e dispositivo per l'attuazione di detto procedimento
DK0472502T3 (da) * 1990-08-24 1995-10-09 Spirig Ag Fremgangsmåde til fremstilling af pellets
JPH0753355A (ja) * 1993-08-11 1995-02-28 Lion Corp 放出が制御された製剤及びそれを含有する持続性製剤
DE4413350A1 (de) * 1994-04-18 1995-10-19 Basf Ag Retard-Matrixpellets und Verfahren zu ihrer Herstellung
WO2000018500A1 (de) * 1998-09-24 2000-04-06 Glatt Systemtechnik Dresden Gmbh Einrichtung zur herstellung eines schüttfähigen produktes und verfahren zur anwendung der einrichtung
JP3447042B2 (ja) * 1997-07-23 2003-09-16 フロイント産業株式会社 単一物質球形粒の製造方法
JPH11279051A (ja) * 1998-03-30 1999-10-12 Nikkiso Co Ltd 透析用剤及びその製造方法
DE19838540C2 (de) * 1998-08-25 2001-07-26 Herbert Huettlin Verfahren zum Behandeln eines partikelförmigen Guts mit einem Überzugsmedium sowie Vorrichtung zur Durchführung eines derartigen Verfahrens
DE19856149C1 (de) * 1998-12-04 2000-06-15 Basf Ag Verfahren zur Herstellung von Agglomeraten mit Kern-Schale-Struktur
GB9827034D0 (en) * 1998-12-10 1999-02-03 Univ Manchester Delivery formulation
JP2001151671A (ja) * 1999-09-06 2001-06-05 Teikoku Hormone Mfg Co Ltd 突起付き粒子製剤
IT1311094B1 (it) * 1999-10-15 2002-02-28 Gs Coating System Srl Macchina per il rivestimento di articoli granulari e simili.
JP4081568B2 (ja) * 2000-03-13 2008-04-30 塩野義製薬株式会社 コーティング方法
CN1325683A (zh) * 2000-05-25 2001-12-12 西藏宇妥藏药研究有限公司 制造藏药丸剂的工艺方法

Also Published As

Publication number Publication date
EP1590144B1 (en) 2015-07-29
EP1590144A1 (en) 2005-11-02
JP2006509803A (ja) 2006-03-23
ES2545454T3 (es) 2015-09-11
JP2014080424A (ja) 2014-05-08
JP5574369B2 (ja) 2014-08-20
CN1747822A (zh) 2006-03-15
CN102805734A (zh) 2012-12-05
EP1590144A4 (en) 2012-02-15
CA2509043A1 (en) 2004-06-24
CA2509043C (en) 2013-08-13
JP2010221049A (ja) 2010-10-07
DK1590144T3 (en) 2015-11-09
WO2004052607A1 (en) 2004-06-24
AU2003298945A1 (en) 2004-06-30

Similar Documents

Publication Publication Date Title
AU2003252299A8 (en) Novel physiologically active substance
HUP0303732A2 (en) Hsa-free formulations of interferon-beta
SI1590144T1 (sl) Postopek za pripravo biološko aktivnih formulacij
IL200255A (en) Method of preparing o-desmethyl-venlafaxine
EP1515698A4 (en) LIPOSOMES CONTAINING BIOLOGICALLY ACTIVE COMPOUNDS
EP1366663A4 (en) METHOD FOR IMPROVING CROPS
AU2003215107A8 (en) Method of "wet-field" scanning
GB0202900D0 (en) Novel formulations of drugs
AU2003213997A1 (en) Biologically active copper-organic agents
EP1667656A4 (en) COMPOSITIONS AND METHODS OF DISTRIBUTING BIOLOGICALLY ACTIVE AGENTS
GB0205347D0 (en) Biologically active complex
GB2412338B (en) Surface preparation of an implant
AU2003225745A8 (en) Free-base formulations of local anesthetics
EP1329516A4 (en) METHOD FOR SCREENING A PHYSIOLOGICALLY ACTIVE SUBSTANCE
EP1488813A4 (en) COMPOSITIONS DELIVERING A BIOLOGICALLY ACTIVE MEDICINE, AND METHOD OF USE
AU2002343197A8 (en) Biologically active complex
HK1091120A1 (en) Method of preparing a formulation containing a microdosed active principle
AU2002362903A1 (en) Method of preparing purified biologically active oligosaccharide libraries
EP1548108A4 (en) SCREENING METHOD FOR IDENTIFYING A SUBSTANCE HAVING PHYSIOLOGICAL ACTIVITY
AU2003300696A8 (en) Chemoenzymatically hydrolysable biologically active compounds
GB0101187D0 (en) Biologically active compounds
GB0216525D0 (en) Biologically active compounds
GB0217239D0 (en) Biologically active compounds
AU2002953257A0 (en) Generation of biologically active compounds
PL357356A1 (en) Method of receiving new biocide active materials